Global Biopsy Devices Market by Type and Size | Industry Report 2016-2022A Story by sumit choudhariBiopsy Devices Market report is an expert analysis report which gives detail information about industry players, segmentation and regional data in-depth. Medical Device Connectivity serves as a proviBiopsy is a type of procedure to remove a piece of
tissue or a sample of cells from a patient’s body. It is majorly used to
extract tissue samples for diagnosis and definitively identify cancerous tissue
and cells. The global market for biopsy devices is growing rapidly. The market
is increasing prevalence of cancer and constantly growing need for high quality
diagnostic and therapeutic processes are majorly responsible for the growth of
the global biopsy devices market. Intended
Audience · Biopsy Devices Manufacturers ·
Biopsy Devices
Suppliers ·
Private Research
Laboratories ·
Research and
Development (R&D) Companies ·
Market Research and
Consulting Service Providers ·
Government Research
Laboratories Biopsy
Devices Market Segmentation: Global biopsy devices market has been
segmented on the basis of product type which comprises of biopsy guns, biopsy
guidance system, biopsy needles, forceps and others. On the basis of
application; market is segmented into surgical biopsy, skin biopsy, needle
biopsy, bone marrow biopsy, Cancer Diagnosis and others. On the basis of end
users; market is segmented hospitals, specialty clinics, diagnostic centers,
academic & research institutes and others. Key Players Fervent players driving the market for the biopsy devices include Precision Biopsy, LLC. (US), Scion Medical Technologies, LLC. (UK), Cook Medical, Hologic, Inc., Leica Biosystems, Argon Medical Devices, Inc., C. R. Bard, Inc., Creganna, Integra LifeSciences Corporation, and Focal Therapeutics,Inc. Regional Analysis The North American region dominates the global biopsy
devices market owing to the extensive adoption of technologically advanced
medical devices, increasing governmental support for R&D activities, and
high health care expenditures.
Furthermore, heading with the increasing prevalence of diabetes, kidney
diseases, and renal failures, the biopsy devices market in North America is
expected to reach USD 2.4 BN by 2022. The European region is another lucrative market for
biopsy devices. The market is driven by the increasing emphasis on the
development of advanced diagnostic devices, increasing funding and support from
the government for R&D activities. Simultaneously, the rising numbers of
specialty services offered by various healthcare providers foster the growth in
the regional market. The Asia Pacific region is rapidly emerging as a
promising market for biopsy devices.
Factors such as growing incidences of diabetes, along with the rising
number of urology centers and kidney transplant procedures are providing
impetus to the market growth. Additionally, factors such as the rapidly
developing healthcare technology along with the increasing demand for quality
devices is expected to fuel the market growth in the APAC region. Table Of Content 1 Introduction 1.1 Definition 1.2 Scope Of Study 1.3 Research Objective 1.4 Assumptions & Limitations 1.5 Market Structure: 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 3 Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Challenges 3.5 Macroeconomic Indicators 4 Market Factor Analysis 4.1 Porter’s Five Forces Model 4.1.1 Bargaining Power Of Suppliers 4.1.2 Bargaining Power Of Customer 4.1.3 Intensity Of Competitor’s 4.1.4 Threat Of New Entrants TOC
Continued….! © 2018 sumit choudhariAuthor's Note
|
StatsAuthor
|